{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T11:19:05Z","timestamp":1774264745938,"version":"3.50.1"},"reference-count":6,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.tmaid.2020.101872","type":"journal-article","created":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T01:14:41Z","timestamp":1599354881000},"page":"101872","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Can influenza vaccine modify COVID-19 clinical course?"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5289-7452","authenticated-orcid":false,"given":"Omar Abdelhay","family":"Eldanasory","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali A.","family":"Rabaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaffar A.","family":"Al-Tawfiq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmaid.2020.101872_bib1","article-title":"Individualizing risk prediction for positive COVID-19 testing: results from 11,672 patients","author":"Jehi","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.tmaid.2020.101872_bib2","article-title":"Influenza vaccination and COVID19 mortality in the USA","volume":"2020","author":"Zanettini","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.tmaid.2020.101872_bib3","doi-asserted-by":"crossref","unstructured":"Fink G, Orlova-Fink N, Schindler T, Grisi S, Ferrer AP, Daubenberger C, et al. Inactivated trivalent influenza vaccine is associated with lower mortality among Covid-19 patients in Brazil n.d. doi:10.1101\/2020.06.29.20142505.","DOI":"10.1101\/2020.06.29.20142505"},{"key":"10.1016\/j.tmaid.2020.101872_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01373","article-title":"Activation of TLR7 and innate immunity as an efficient method against COVID-19 pandemic: imiquimod as a potential therapy","volume":"11","author":"Poulas","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.tmaid.2020.101872_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30193-4","article-title":"Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures","volume":"8","author":"Hui","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.tmaid.2020.101872_bib6","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-10-18","article-title":"Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model","volume":"10","author":"Coudeville","year":"2010","journal-title":"BMC Med Res Methodol"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893920303689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893920303689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:07:58Z","timestamp":1761487678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893920303689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":6,"alternative-id":["S1477893920303689"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2020.101872","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can influenza vaccine modify COVID-19 clinical course?","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2020.101872","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101872"}}